mobile menugoto home

Highlights

Interactive debate session part 1: How do SGLT2 inhibitors fit into individualized management of type 2 diabetes?Stumvoll, Prof. M.
SGLT2 inhibitors: efficacyCeriello, Prof. A.
Clinical experience: how can GLP-1 receptor agonists improve daily life for patients?Vilsboll, Dr. T.
SGLT2 inhibitors: new outcome studiesSeufert, Prof. J.
Michael Berger debate - Metformin: where is the evidence?Lebovitz, Prof. H. E.
Interactive debate session part 3: How do SGLT2 inhibitors fit into individualized management of type 2 diabetes?Stumvoll, Prof. M.

Webcasts of Diabetes Symposia

15-Sep-14 , Vienna, Austria
15-Sep-14 , Vienna, Austria
18-Sep-14 , Vienna, Austria
16-Sep-14 , Vienna, Austria
01-Sep-14 , ESC Congress 2014, Barcelona, Spain
05-Dec-13 , Forschergruppe Diabetes e.V. + D&CVD EASD Study Group

World Diabetes Congress, Melbourne, Australia

05-Dec-13 , Forschergruppe Diabetes e.V. + D&CVD EASD Study Group

World Diabetes Congress, Melbourne, Australia

23-Sep-13 , Barcelona, Spain
23-Sep-13 , Barcelona, Spain
23-Sep-13 , Barcelona, Spain

diabetes-symposium.org

The symposium is an innovative platform for
continuing medical education.

Selected lectures by highly qualified experts are
presented in a virtual mode.

International symposia on cardiovascular disease:
www.cardio-symposium.org

Annual Conferences of the Federation of European Nurses in Diabetes (FEND)
www.fend-lectures.org

 

Also on Smartphone & Tablet PC
Our webcasts are now available on your smartphone (e.g. iPhone) or tablet PC (e.g. iPad)

Newsletter
Stay informed with latest updates on webcasts of international medical symposia. Sign up for our free email newsletter.